A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Geoerger, Birgit, Bourdeaut, Franck, DuBois, Steven G, Fischer, Matthias, Geller, James I, Gottardo, Nicholas G, Marabelle, Aurélien, Pearson, Andrew D J, Modak, Shakeel, Cash, Thomas, Robinson, Giles W, Motta, Marlyane, Matano, Alessandro, Bhansali, Suraj G, Dobson, Jason R, Parasuraman, Sudha, Chi, Susan N
Published in Clinical cancer research (15.05.2017)
Published in Clinical cancer research (15.05.2017)
Get full text
Journal Article
709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors
Chattopadhyay, Shrikanta, Boudot, Antoine J, Nayar, Ribhu, Bader, Hannah, Ferretti, Andrew, Traore, Tary, Nabilsi, Nancy, Tadros, Jenny, Kiaf, Badr, Wang, Yifan, Ospina, Victor, Mahopatra, Alok Das, Zhu, Zhonghua, Xu, Qikai, Daniels, Krista, Zimmerman, Briana, Jurewicz, Mollie, Kordosky, Amanda, Malcuit, Chris, Wang, Yun, Motta, Marlyane, Murray, Jim, Lockard, Ray, Gurer, Cagan, Barton, Debora, MacBeath, Gavin
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
801 PRIME™ IL-15 (RPTR-147): Preliminary clinical results and biomarker analysis from a first-in-human Phase 1 study of IL-15 loaded peripherally-derived autologous T cell therapy in solid tumor patients
Hamilton, Erika, Nikiforow, Sarah, Bardwell, Philip, McInnis, Christine, Zhang, Jeffrey, Blumenschein, George, Cristea, Mihaela, Osman, Keren, Shields, Anthony, Motta, Marlyane, Bilic, Sanela, Schoenborn-Kellenberger, Oliver, Rakestraw, James, Carey, Shawn, Geretti, Elena, Sauer, Karsten, Harris, Tim, Maniar, Tap, Hewes, Becker, Andresen, Thomas, Fitzgerald, Jonathan, Kluger, Harriet
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
Product characteristics and clinical trial design for T-Plex: Multiplexed, enhanced T cell receptor engineered T cell therapy for solid tumors
Chattopadhyay, Shrikanta, Boudot, Antoine, Nayar, Ribhu, Bader, Hannah, Nabilsi, Nancy, Tadros, Jenny, Kiaf, Badr, Wang, Yifan, Kordosky, Amanda, Malcuit, Chris, Wang, Yun, Motta, Marlyane, Abelowitz, Nina, Lockard, Ray, Gurer, Cagan, Barton, Debora, MacBeath, Gavin
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Initial data from a phase 1, first-in-human clinical trial for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy (TCR-T) for solid tumors
Thomas, Sajeve Samuel, Pico, Brian, Henick, Brian S., Leidner, Rom, Samhouri, Yazan, Isaacs, James, Weiss, Jared, Hurwitz, Michael E., Grewal, Jaspreet Singh, Luke, Jason J., Chattopadhyay, Shrikanta, Wang, Yun, Motta, Marlyane, Murray, Jim, Barton, Debora, Pinchasik, Dawn, MacBeath, Gavin, Moser, Justin C
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Abstract CT170: Trial in progress: A phase 1, first in human clinical trial for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy (TCR-T) for solid tumors
Moser, Justin, Pico, Brian, Henick, Brian, Leidner, Rom, Weiss, Jared, Isaacs, James, Grewal, Jaspreet, Hurwitz, Michael, Murray, Jim, Motta, Marlyane, Wang, Yun, Chattopadhyay, Shrikanta, Barton, Debora, MacBeath, Gavin, Thomas, Sajeve
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article